Hydroxysafflor yellow A reduces myocardial infarction size after coronary artery ligation in rats

By Tian Wang   Feng-Hua Fu   Bing Han   Gui-Sheng Li   Lei-Ming Zhang   Ke Liu  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 47, Iss. 5, 2009-05 ,pp. : 458-462

Informa Healthcare

Access to resources Recommend Favorite

Adenosine A₁ receptor-mediated inhibition of myocardial norepinephrine release involves neither phospholipase C nor protein kinase C but does involve adenylyl cyclase

By Schütte Frank   Burgdorf Christof   Richardt Gert   Kurz Thomas  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 5, 2006-05 ,pp. : 573-577

NRC Research Press

Access to resources Recommend Favorite

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat

By Zacharowski K.   Blackburn B.   Thiemermann C.  

European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Kaempferide-7- O -(4′′- O -acetylrhamnosyl)-3- O -rutinoside reduces myocardial infarction Size after coronary artery ligation in rats

By Eerduna Gaowa   Wei Dongsheng   Yu Xiaofeng   Qu Shaochun   Sui Dayuan  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 6, 2013-06 ,pp. : 453-458

Govi-Verlag

Access to resources Recommend Favorite

Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats

By Gunther J.   Wagner K.-D.   Theres H.   Schimke I.   Born A.   Scholz H.   Vetter R.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite